Assay platform for clinically relevant metallo-β-lactamases

Journal of Medicinal Chemistry

Volumn 56, Issue 17, 2013, Pages 6945-6953

  Van Berkel, Sander S ^a   Brem, Jürgen ^a   Rydzik, Anna M ^a   Salimraj, Ramya ^b   Cain, Ricky ^d   Verma, Anil ^a,c   Owens, Raymond J ^a,c   Fishwick, Colin W G ^d   Spencer, James ^b   Schofield, Christopher J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c RUTHERFORD APPLETON LABORATORY   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN DERIVATIVE; CHROMOGENIC SUBSTRATE; IMIPENEM; METALLO BETA LACTAMASE; NITROCEFIN; UMBELLIFERONE;

ARTICLE; DRUG IDENTIFICATION; DRUG SCREENING; DRUG SENSITIVITY; DRUG SYNTHESIS; ENZYME ASSAY;

BETA-LACTAMASES; ENZYME INHIBITORS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; METALS;

EID: 84884245033     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm400769b     Document Type: Article

References (70)

1. Spellberg, B.; Guidos, R.; Gilbert, D.; Bradley, J.; Boucher, H. W.; Scheld, W. M.; Bartlett, J. G.; Edwards, J., Jr. The epidemic of antibiotic-resistant infections: A call to action for the medical community from the Infectious Diseases Society of America Clin. Infect. Dis. 2008, 46, 155-164
2. World Health Organization. The evolving threat of antimicrobialresistance: Options for action, (2012. http://whqlibdoc.who.int/ publications/2012/9789241503181-eng.pdf (accessed December 2012).
3. Bush, K.; Jacoby, G. A. Updated functional classification of β-lactamases Antimicrob. Agents Chemother. 2010) 54, 969-976
4. White, A. R.; Kaye, C.; Poupard, J.; Pypstra, R.; Woodnutt, G.; Wynne, B. J. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: A review of the continuing development of an innovative antimicrobial agent Antimicrob. Chemother. 2004, 53 (Suppl. S1) i3-i20
5. Drawz, S. M.; Bonomo, R. A. Three decades of β-lactamase inhibitors Clin. Microbiol. Rev. 2010, 23, 160-201
6. Oelschlaeger, P.; Ai, N.; DuPrez, K. T.; Welsh, W. J.; Toney, J. H. Evolving carbapenemases: Can medicinal chemists advance one step ahead of the coming storm? J. Med. Chem. 2010, 53, 3013-3027
7. Papp-Wallace, K. M.; Endimiani, A.; Taracila, M. A.; Bonomo, R. A Carbapenems: Past, present, and future Antimicrob. Agents Chemother. 2011, 5, 4943-4960
8. Ehmann, D. E.; Jahić, H.; Ross, P. L.; Gu, R.-F.; Hu, J.; Kern, G.; Walkup, G. K.; Fisher, S. L. Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 11663-11668
9. Ellar, D. J.; Lundgren, D. G. Fine structure of sporulation in Bacillus cereus grown in a chemically defined medium J. Bacteriol. 1966, 92, 1748-1764
10. Walsh, T. R. Emerging carbapenemases: A global perspective Int. J. Antimicrob. Agents 2010, 36 (Suppl. 3) S8-S14
11. Cornaglia, G.; Giamarellou, H.; Maria Rossolini, G. Metallo-β- lactamases: A last frontier for β-lactams? Lancet Infect. Dis. 2011, 11, 381-393
12. Chen, P.; Horton, L. B.; Mikulski, R. L.; Deng, L.; Sundriyal, S.; Palzkill, T.; Song, Y. 2-Substituted 4,5-dihydrothiazole-4-carboxylic acids are novel inhibitors of metallo-β-lactamases Bioorg. Med. Chem. Lett. 2012, 22, 6229-6232
13. Toney, J. H.; Hammond, G. G.; Fitzgerald, P. M. D.; Sharma, N.; Balkovec, J. M.; Rouen, G. P.; Olson, S. H.; Hammond, M. L.; Greenlee, M. L.; Gao, Y. D. Succinic acids as potent inhibitors of plasmid-borne IMP-1 metallo-β- lactamase J. Biol. Chem. 2001, 276, 31913-31918
14. Toney, J. H.; Fitzgerald, P. M.; Grover-Sharma, N.; Olson, S. H.; May, W. J.; Sundelof, J. G.; Vanderwall, D. E.; Cleary, K. A.; Grant, S. K.; Wu, J. K.; Kozarich, J. W.; Pompliano, D. L.; Hammond, G. G. Antibiotic sensitization using biphenyl tetrazoles as potent inhibitors of Bacteroides fragilis metallo-β-lactamase Chem. Biol. 1998, 5, 185-196
15. Weide, T.; Saldanha, S. A.; Minond, D.; Spicer, T. P.; Fotsing, J. R.; Spaargaren, M.; Frère, J.-M.; Bebrone, C.; Sharpless, K. B.; Hodder, P. S.; Fokin, V. V. NH-1,2,3-Triazole-based inhibitors of the VIM-2 metallo-β-lactamase: Synthesis and structure-activity studies ACS Med. Chem. Lett. 2010, 1, 150-154
16. Liénard, B. M. R.; Garau, G.; Horsfall, L.; Karsisiotis, A. I.; Damblon, C.; Lassaux, P.; Papamicael, C.; Roberts, G. C. K.; Galleni, M.; Dideberg, O.; Frère, J.-M.; Schofield, C. J. Structural basis for the broad-spectrum inhibition of metallo-β-lactamases by thiols Org. Biomol. Chem. 2008, 6, 2282-2294
17. Liénard, B. M., R.; Hüting, R.; Lassaux, P.; Galleni, M.; Frère, J.-M.; Schofield, C. J. Dynamic combinatorial mass spectrometry leads to metallo-β-lactamase inhibitors J. Med. Chem. 2008, 51, 684-688
18. Walter, M. W.; Felici, A.; Galleni, M.; Paul Soto, R.; Adlington, R. M.; Baldwin, J. E.; Frère, J.-M.; Gololobov, M.; Schofield, C. J. Trifluoromethyl alcohol and ketone inhibitors of metallo-β-lactamases Bioorg. Med. Chem. Lett. 1996, 6, 2455-2458
19. Fast, W.; Sutton, L. D. Metallo-β-lactamase: Inhibitors and reporter substrates Biochim. Biophys. Acta, Proteins Proteomics 2013, 1834, 1648-1659
20. Toney, J. H.; Moloughney, J. G. Metallo-β-lactamase inhibitors: Promise for the future? Curr. Opin. Invest. Drugs 2004, 5, 823-826
21. Spencer, J.; Walsh, T. R.; New, A. Approach to the inhibition of metallo-β-lactamases Angew. Chem., Int. Ed. 2006, 45, 1022-1026
22. Moali, C.; Anne, C.; Lamotte-Brasseur, J.; Groslambert, S.; Devreese, B.; Van Beeumen, J.; Galleni, M.; Frère, J.-M. Analysis of the importance of the metallo-β-lactamase active site loop in substrate binding and catalysis Chem. Biol. 2003, 10, 319-329
23. Saradhi Borra, P.; Samuelsen, Ø.; Spencer, J.; Walsh, T. R.; Sjo Lorentzen, M.; Leirose, H.-K. S. Crystal structures of Pseudomonas aeruginosa GIM-1: Active-site plasticity in metallo-β-lactamases Antimicrob. Agents Chemother. 2013, 57, 848-854
24. Viswanatha, T.; Marrone, L.; Goodfellow, V.; Dmitrienko, G. I. Assays for β-lactamase activity and inhibition Methods Mol. Med. 2008, 142, 239-260
25. Kocaoglu, O.; Calvo, R. A.; Sham, L.-T.; Cozy, L. M.; Lanning, B. R.; Francis, S.; Winkler, M. E.; Kearns, D. B.; Carlson, E. E. Selective penicillin-binding protein imaging probes reveal substructure in bacterial cell division ACS Chem. Biol. 2012, 7, 1746-1753
26. Zheng, X.; Sallium, U. W.; Verma, S.; Athar, H.; Evans, C. L.; Hasan, T. Exploiting a bacterial drug-resistance mechanism: A light-activated construct for the destruction of MRSA Angew. Chem., Int. Ed. 2009, 48, 2148-2151
27. Jones, R. N.; Wilson, H. W.; Novick, W. J., Jr.; Barry, A. L.; Thornberry, C. In vitro evaluation of CENTA, a new β-lactamase-susceptible chromogenic cephalosporin reagent J. Clin. Microbiol. 1982, 15, 954-958
28. Jones, R. N.; Wilson, H. W.; Novick, J.R. In vitro evaluation of pyridine-2-azo- p -dimethylaniline cephalosporin, a new diagnostic chromogenic reagent, and comparison with nitrocefin, cephacetrile, and other β-lactam compounds J. Clin. Microbiol. 1982, 15, 677-683
29. Shannon, K.; Phillips, I. β-Lactamase detection by three simple methods: Intralactam, nitrocefin and acidimetric J. Antimicrob. Chemother. 1980, 6, 617-621
30. Gao, W.; Xing, B.; Tsien, R. Y.; Rao, J. Novel fluorogenic substrates for imaging β-lactamase gene expression J. Am. Chem. Soc. 2003, 125, 11146-11147
31. Rukavishnikov, A.; Gee, K. R.; Johnson, I.; Corry, S. Fluorogenic cephalosporin substrates for β-lactamase TEM-1 Anal. Biochem. 2011, 419, 9-16
32. Zhang, Y.-L.; Xiao, J.-M.; Feng, J.-L.; Yang, K.-W.; Feng, L.; Zhou, L.-S.; Crowder, M. W. A novel fluorogenic substrate for dinuclear Zn(II)-containing metallo-β-lactamases Bioorg. Med. Chem. Lett. 2013, 23, 1676-1679
33. Yao, H.; So, M.-K.; Rao, J.; Bioluminogenic, A. Substrate for in vivo imaging of β-lactamase activity Angew. Chem., Int. Ed. 2007, 46, 7031-7034
34. Watanabe, S.; Mizukami, S.; Hori, Y.; Kikuchi, K. Multicolor protein labeling in living cells using mutant β-lactamase-tag technology Bioconjugate Chem. 2010, 21, 2320-2326
35. Mizukami, S.; Watanabe, S.; Akimoto, Y.; Kikuchi, K. No-wash protein labeling with designed fluorogenic probes and application to real-time pulse-chase analysis J. Am. Chem. Soc. 2012, 134, 1623-1629
36. Shao, Q.; Xing, B. Enzyme responsive luminescent ruthenium(II) cephalosporin probe for intracellular imaging and photoinactivation of antibiotics resistant bacteria Chem. Commun. 2012, 48, 1739-1741
37. Griffin, D. H.; Richmond, T. K.; Sanchez, C.; Jon Moller, A.; Breece, R. M.; Tierney, D. L.; Bennett, B.; Crowder, M. W. Structural and kinetic studies on metallo-β-lactamase IMP-1 Biochemistry 2011, 50, 9125-9134 (IMP-1)
38. de Seny, D.; Prosperi-Meys, C.; Bebrone, C.; Maria Rossolini, G.; Page, M. I.; Noel, P.; Frère, J.-M.; Galleni, M. Mutational analysis of the two zinc-binding sites of the Bacillus cereus 569/H/9 metallo-β-lactamase Biochem. J. 2002, 363, 687-696 (Bc II)
39. Green, V. L.; Verma, A.; Owens, R. J.; Phillipsa, S. E. V.; Carr, S. B. Structure of New Delhi metallo-β-lactamase 1 (NDM-1) Acta Crystallogr. 2011, F67, 1160-1164 (NDM-1)
40. Berrow, N. S.; Alderton, D.; Sainsbury, S.; Nettleship, J.; Assenberg, R.; Rahman, N.; Stuart, D. I.; Owens, R. J. A versatile ligation-independent cloning method suitable for high-throughput expression screening applications Nucleic Acids Res. 2007, 35, e45
41. Bebrone, C.; Moali, C.; Mahy, F.; Rival, S.; Docquier, J.-D.; Maria Rossolini, G.; Fastrez, J.; Pratt, R. F.; Frère, J.-M.; Galleni, M. CENTA as a chromogenic substrate for studying β-lactamases Antimicrob. Agents Chemother. 2001, 45, 1868-1871
42. 3-cephem by oxidation-reduction at sulfur J. Org. Chem. 1970, 35, 2430-2433
43. Goddard, J.-P.; Reymond, J.-L. Enzyme assays for high-throughput screening Curr. Opin. Biotechnol. 2004, 15, 314-322
44. Xie, H.; Mire, J.; Kong, Y.; Chang, M.; Hassounah, H. A.; Thornton, C. N.; Sacchettini, J. C.; Cirillo, J. D.; Rao, J. Rapid point-of-care detection of the tuberculosis pathogen using a BlaC-specific fluorogenic probe Nat. Chem. 2012, 4, 802-809
45. Kim, Y.; Tesar, C.; Mire, J.; Jedrzejczak, R.; Binkowski, A.; Babnigg, G.; Sacchettini, J.; Joachimiak, A. Structure of apo- and monometalated forms of NDM-1-A highly potent carbapenem-hydrolyzing metallo-β-lactamase PLoS One 2011, 6, e24621
46. Docquier, J.-D.; Lamotte-Brasseur, J.; Galleni, M.; Amicosante, G.; Frère, J.-M.; Maria Rossolini, G. On functional and structural heterogeneity of VIM-type metallo-β-lactamases J. Antimicrob. Chemother. 2003, 51, 257-266
47. Laraki, N.; Franceschini, N.; Rossolini, G. M.; Santucci, P.; Meunier, C.; de Pauw, E.; Amicosante, G.; Frère, J.-M.; Galleni, M. Biochemical characterization of the Pseudomonas aeruginosa 101/1477 metallo-β-lactamase IMP-1 produced by Escherichia coli Antimicrob. Agents Chemother. 1999, 43, 902-906
48. Murphy, T. A.; Simm, A. M.; Toleman, M. A.; Jones, R. N.; Walsh, T. R. Biochemical characterization of the acquired metallo-β-lactamase SPM-1 from Pseudomonas aeruginosa Antimicrob. Agents Chemother. 2003, 47, 582-587
49. Paul-Soto, R.; Hernadez-Valladares, M.; Fonzé, E.; Goussard, S.; Courvalin, P.; Frère, J.-M. Mono- and binuclear Zn-β-lactamase from Bacteroides fragilis: Catalytic and structural roles of the zinc ions FEBS Lett. 1998, 438, 137-140
50. Felici, A.; Amicosante, G. Kinetic Analysis of extension of substrate specificity with Xanthomonas maltophilia, Aeromonas hydrophila, and Bacillus cereus metallo-β-lactamases Antimicrob. Agents Chemother. 1995, 39, 192-199
51. NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India Antimicrob. Agents Chemother. 2009, 53, 5046-5054
52. Badarau, A.; Llinás, A.; Laws, A. P.; Damblon, C.; Page, M. I. Inhibitors of metallo-β-lactamase generated from β-lactam antibiotics Biochemistry 2005, 44, 8578-8589
53. Astrid Zervosen, A.; Hernandez Valladares, M.; Devreese, B.; Prosperi-Meys, C.; Adolph, H.-W.; Sandra Mercuri, P.; Vanhove, M.; Amicosante, G.; van Beeumen, J.; Frère, J.-M.; Galleni, M. Inactivation of Aeromonas hydrophila metallo-β-lactamase by cephamycins and moxalactam Eur. J. Biochem. 2001, 268, 3840-3850
54. Fonseca, F.; Arthur, C. J.; Bromley, E. H. C.; Samyn, B.; Moerman, P.; Saavedra, M. J.; Correia, A.; Spencer, J. Biochemical characterization of Sfh-I, a subclass B2 metallo-β-lactamase from Serratia fonticola UTAD54 Antimicrob. Agents Chemother. 2011, 55, 5392-5395
55. Siemann, S.; Clarke, A. J.; Viswanatha, T.; Dmitrienko, G. I. Thiols as classical and slow-binding inhibitors of IMP-1 and other binuclear metallo-β-lactamases Biochemistry 2003, 42, 1673-1683
56. Badarau, A.; Llinas, A.; Laws, A. P.; Damblon, C.; Page, M. I. Inhibitors of metallo-β-lactamase generated from β-lactam antibiotics Biochemistry 2005, 44, 8578-8589
57. Murphy, T. A; Catto, L. E.; Halford, S. E.; Hadfield, A. T.; Minor, W.; Walsh, T. R.; Spencer, J. Crystal structure of Pseudomonas aeruginosa SPM-1 provides insights into variable zinc affinity of metallo-β-lactamases J. Mol. Biol. 2006, 357, 890-903
58. Zhang, H.; Hao, Q. Crystal structure of NDM-1 reveals a common β-lactam hydrolysis mechanism FASEB J. 2011, 25, 2574-2582
59. Garcia-Saez, I.; Docquier, J. D.; Rossolini, G. M.; Dideberg, O. The three-dimensional structure of VIM-2, a Zn-β-lactamase from Pseudomonas aeruginosa in its reduced and oxidised form J. Mol. Biol. 2008, 375, 604-611
60. Goodsell, D. S.; Morris, G. M.; Olson, A. J. Automated docking of flexible ligands: Applications of AutoDock J. Mol. Recognit. 1996, 9, 1-5
61. Morris, G. M.; Huey, R.; Lindstrom, W.; Sanner, M. F.; Belew, R. K.; Goodsell, D. S.; Olson, A. J. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility J. Comput. Chem. 2009, 30, 2785-2791
62. Gillet, V.; Johnson, A. P.; Mata, P.; Sike, S.; Williams, P. SPROUT: A program for structure generation J. Comput.-Aided Mol. Des. 1993, 7, 127-153
63. Gillet, V. J.; Newell, W.; Mata, P.; Myatt, G.; Sike, S.; Zsoldos, Z.; Johnson, A. P. SPROUT: Recent developments in the de novo design of molecules J. Chem. Inf. Comput. Sci. 1994, 34, 207-217
64. Cadag, E.; Vitalis, E.; Lennox, K. P.; Zhou, C. L. E.; Zemla, A. T. Computational analysis of pathogen-borne metallo β-lactamases reveals discriminating structural features between B1 types BMC Res. Notes 2012, 5, 96
65. Stubbs, C. J.; Loenarz, C.; Mecinović, J.; Kheng Yeoh, K.; Hindley, N.; Liénard, B. M.; Sobott, F.; Schofield, C. J.; Flashman, E. Application of a proteolysis/mass spectrometry method for investigating the effects of inhibitors on hydroxylase structure J. Med. Chem. 2009, 52, 2799-2805
66. Tian, Y.-M.; Yeoh, K. K.; Lee, M. K.; Eriksson, T.; Kessler, B. M.; Kramer, H. B.; Edelmann, M. J.; Willam, C.; Pugh, C. W.; Schofield, C. J.; Ratcliffe, P. J. Differential sensitivity of hypoxia inducible factor hydroxylation sites to hypoxia and hydroxylase inhibitors J. Biol. Chem. 2011, 286, 13041-13051
67. Heinz, U.; Bauer, R.; Wommer, S.; Meyer-Klaucke, W.; Papamichaels, C.; Bateson, J.; Adolph, H.-W. Coordination geometries of metal ions in D- or L-captopril-inhibited metallo-β-lactamases J. Biol. Chem. 2003, 278, 20659-20666
68. King, D. T.; Worrall, L. J.; Gruninger, R.; Strynadka, N. C. New Delhi metallo-β-lactamase: Structural insights into β-lactam recognition and inhibition J. Am. Chem. Soc. 2012, 134, 11362-11365
69. i values for inhibitors of enzyme activity and ligand binding Nucleic Acids Res. 2009, 37, W441-W445
70. Guo, Y.; Wang, J.; Niu, G.; Shui, W.; Sun, Y.; Zhou, H.; Zhang, Y.; Yang, C.; Lou, Z.; Rao, Z. A structural view of the antibiotic degradation enzyme NDM-1 from a superbug Protein Cell 2011, 2, 384-394